A new series of thiazole nortopsentin analogues was conveniently synthesized with fair overall yields. The antiproliferative activity of the new derivatives was tested against different human tumor cell lines of the NCI full panel. Four of them showed good antitumor activity with GI(50) values from micro to nanomolar level. The mechanism of the antiproliferative effect of these derivatives, was pro-apoptotic, being associated with externalization of plasma membrane phosphatidylserine and DNA fragmentation. The most active and selective of the new thiazoles confined viable cells in G2/M phase and markedly inhibited in vitro CDK1 activity. (C) 2017 Elsevier Masson SAS.

Parrino, B., Attanzio, A., Spanò, V., Cascioferro, S., Montalbano, A., Barraja, P., et al. (2017). Synthesis, antitumor activity and CDK1 inhibiton of new thiazole nortopsentin analogues. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 138, 371-383 [10.1016/j.ejmech.2017.06.052].

Synthesis, antitumor activity and CDK1 inhibiton of new thiazole nortopsentin analogues

PARRINO, Barbara;ATTANZIO, Alessandro;SPANO', Virginia;CASCIOFERRO, Stella Maria;MONTALBANO, Alessandra;BARRAJA, Paola;TESORIERE, Luisa;DIANA, Patrizia;CIRRINCIONE, Girolamo;CARBONE, Anna
2017-01-01

Abstract

A new series of thiazole nortopsentin analogues was conveniently synthesized with fair overall yields. The antiproliferative activity of the new derivatives was tested against different human tumor cell lines of the NCI full panel. Four of them showed good antitumor activity with GI(50) values from micro to nanomolar level. The mechanism of the antiproliferative effect of these derivatives, was pro-apoptotic, being associated with externalization of plasma membrane phosphatidylserine and DNA fragmentation. The most active and selective of the new thiazoles confined viable cells in G2/M phase and markedly inhibited in vitro CDK1 activity. (C) 2017 Elsevier Masson SAS.
2017
Parrino, B., Attanzio, A., Spanò, V., Cascioferro, S., Montalbano, A., Barraja, P., et al. (2017). Synthesis, antitumor activity and CDK1 inhibiton of new thiazole nortopsentin analogues. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 138, 371-383 [10.1016/j.ejmech.2017.06.052].
File in questo prodotto:
File Dimensione Formato  
E. J. Med. Chem. 138 (2017) 371-383.pdf

Solo gestori archvio

Descrizione: Articolo principale
Tipologia: Versione Editoriale
Dimensione 1.23 MB
Formato Adobe PDF
1.23 MB Adobe PDF   Visualizza/Apri   Richiedi una copia

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/10447/238423
Citazioni
  • ???jsp.display-item.citation.pmc??? 20
  • Scopus 68
  • ???jsp.display-item.citation.isi??? 64
social impact